The role of Smad signaling in hematopoiesis and translational hematology

Leukemia

Volumn 25, Issue 9, 2011, Pages 1379-1388

  Blank, U ^a   Karlsson, S ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hematopoietic stem cell; smad signaling; TGF

Indexed keywords

BONE MORPHOGENETIC PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; HEMATOLOGIC MALIGNANCY; HEMATOLOGY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL EXPANSION; TRANSLATIONAL RESEARCH;

ANIMALS; HEMATOLOGY; HEMATOPOIESIS; HUMANS; MICE; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA;

EID: 80052445124     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2011.95     Document Type: Review

References (130)

1. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998; 67: 753-791.
2. Gordon KJ, Blobe GC. Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta 2008; 1782: 197-228.
3. Massague J. TGFbeta in cancer. Cell 2008; 134: 215-230.
4. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-beta: pleiotropic role in the regulation of hematopoiesis. Blood 2000; 96: 2022-2036.
5. Larsson J, Karlsson S. The role of Smad signaling in hematopoiesis. Oncogene 2005; 24: 5676-5692. (Pubitemid 43086128)
6. Ruscetti FW, Akel S, Bartelmez SH. Autocrine transforming growth factor-beta regulation of hematopoiesis: many outcomes that depend on the context. Oncogene 2005; 24: 5751-5763. (Pubitemid 43086135)
7. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19: 2783-2810. (Pubitemid 41739965)
8. Heldin CH, Miyazono K, ten Dijke P. TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 1997; 390: 465-471. (Pubitemid 28013118)
9. Garbe A, Spyridonidis A, Mobest D, Schmoor C, Mertelsmann R, Henschler R. Transforming growth factor-beta 1 delays formation of granulocyte-macrophage colony-forming cells, but spares more primitive progenitors during ex vivo expansion of CD34+ haemopoietic progenitor cells. Br J Haematol 1997; 99: 951-958. (Pubitemid 28047166)
10. Batard P, Monier MN, Fortunel N, Ducos K, Sansilvestri-Morel P, Phan T et al. TGF-(beta)1 maintains hematopoietic immaturity by a reversible negative control of cell cycle and induces CD34 antigen up-modulation. J Cell Sci 2000; 113 (Part 3): 383-390. (Pubitemid 30116645)
11. Sitnicka E, Ruscetti FW, Priestley GV, Wolf NS, Bartelmez SH. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells. Blood 1996; 88: 82-88. (Pubitemid 26230674)
12. Soma T, Yu JM, Dunbar CE. Maintenance of murine long-term repopulating stem cells in ex vivo culture is affected by modulation of transforming growth factor-beta but not macrophage inflammatory protein-1 alpha activities. Blood 1996; 87: 4561-4567. (Pubitemid 26000292)
13. Fortunel N, Batard P, Hatzfeld A, Monier MN, Panterne B, Lebkowski J et al. High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells. J Cell Sci 1998; 111 (Part 13): 1867-1875. (Pubitemid 28370531)
14. Hatzfeld J, Li ML, Brown EL, Sookdeo H, Levesque JP, Toole T et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor beta 1 or Rb oligonucleotides. J Exp Med 1991; 174: 925-929.
15. Dao MA, Hwa J, Nolta JA. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood 2002; 99: 499-506. (Pubitemid 34533084)
16. Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci USA 1998; 95: 13006-13011.
17. Dubois CM, Ruscetti FW, Palaszynski EW, Falk LA, Oppenheim JJ, Keller JR. Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action. J Exp Med 1990; 172: 737-744. (Pubitemid 20301220)
18. Dubois CM, Ruscetti FW, Stankova J, Keller JR. Transforming growth factor-beta regulates c-kit message stability and cell-surface protein expression in hematopoietic progenitors. Blood 1994; 83: 3138-3145.
19. Ducos K, Panterne B, Fortunel N, Hatzfeld A, Monier MN, Hatzfeld J. p21(cip1) mRNA is controlled by endogenous transforming growth factor-beta1 in quiescent human hematopoietic stem/progenitor cells. J Cell Physiol 2000; 184: 80-85. (Pubitemid 30349630)
20. Jacobsen SE, Ruscetti FW, Dubois CM, Lee J, Boone TC, Keller JR. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Blood 1991; 77: 1706-1716.
21. Sansilvestri P, Cardoso AA, Batard P, Panterne B, Hatzfeld A, Lim B et al. Early CD34high cells can be separated into KIThigh cells in which transforming growth factor-beta (TGF-beta) downmodulates c-kit and KITlow cells in which anti-TGF-beta upmodulates c-kit. Blood 1995; 86: 1729-1735.
22. Cheng T, Shen H, Rodrigues N, Stier S, Scadden DT. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21(Cip1/Waf1) or p27(Kip1). Blood 2001; 98: 3643-3649.
23. Scandura JM, Boccuni P, Massague J, Nimer SD. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation. Proc Natl Acad Sci USA 2004; 101: 15231-15236. (Pubitemid 39391747)
24. Yamazaki S, Iwama A, Takayanagi S, Morita Y, Eto K, Ema H et al. Cytokine signals modulated via lipid rafts mimic niche signals and induce hibernation in hematopoietic stem cells. EMBO J 2006; 25: 3515-3523. (Pubitemid 44264862)
25. Yamazaki S, Iwama A, Takayanagi S, Eto K, Ema H, Nakauchi H. TGF-beta as a candidate bone marrow niche signal to induce hematopoietic stem cell hibernation. Blood 2009; 113: 1250-1256.
26. Shi Y, Massague J. Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 2003; 113: 685-700. (Pubitemid 36724933)
27. Piek E, Heldin CH, Ten Dijke P. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB J 1999; 13: 2105-2124.
28. Langer JC, Henckaerts E, Orenstein J, Snoeck HW. Quantitative trait analysis reveals transforming growth factor-beta2 as a positive regulator of early hematopoietic progenitor and stem cell function. J Exp Med 2004; 199: 5-14. (Pubitemid 38076473)
29. Henckaerts E, Langer JC, Orenstein J, Snoeck HW. The positive regulatory effect of TGF-beta2 on primitive murine hemopoietic stem and progenitor cells is dependent on age, genetic background, and serum factors. J Immunol 2004; 173: 2486-2493. (Pubitemid 39063106)
30. Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, Lyons K et al. Long-term propagation of distinct hematopoietic differentiation programs in vivo. Cell Stem Cell 2007; 1: 218-229. (Pubitemid 47215588)
31. Sieburg HB, Cho RH, Dykstra B, Uchida N, Eaves CJ, Muller-Sieburg CE. The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets. Blood 2006; 107: 2311-2316. (Pubitemid 43345549)
32. Wilson A, Laurenti E, Oser G, van der Wath RC, Blanco-Bose W, Jaworski M et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell 2008; 135: 1118-1129.
33. Challen GA, Boles NC, Chambers SM, Goodell MA. Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1. Cell Stem Cell 2010; 6: 265-278.
34. Yaswen L, Kulkarni AB, Fredrickson T, Mittleman B, Schiffman R, Payne S et al. Autoimmune manifestations in the transforming growth factor-beta 1 knockout mouse. Blood 1996; 87: 1439-1445. (Pubitemid 26056908)
35. Letterio JJ, Geiser AG, Kulkarni AB, Dang H, Kong L, Nakabayashi T et al. Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. J Clin Invest 1996; 98: 2109-2119. (Pubitemid 26376300)
36. Leveen P, Larsson J, Ehinger M, Cilio CM, Sundler M, Sjostrand LJ et al. Induced disruption of the transforming growth factor beta type II receptor gene in mice causes a lethal inflammatory disorder that is transplantable. Blood 2002; 100: 560-568. (Pubitemid 34761120)
37. Capron C, Lacout C, Lecluse Y, Jalbert V, Chagraoui H, Charrier S et al. A major role of TGF-{beta}1 in the homing capacities of murine hematopoietic stem cell/progenitors. Blood 2010; 116: 1244-1253.
38. Larsson J, Blank U, Helgadottir H, Bjornsson JM, Ehinger M, Goumans MJ et al. TGF-beta signaling-deficient hematopoietic stem cells have normal self-renewal and regenerative ability in vivo despite increased proliferative capacity in vitro. Blood 2003; 102: 3129-3135. (Pubitemid 37314748)
39. Larsson J, Blank U, Klintman J, Magnusson M, Karlsson S. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo. Exp Hematol 2005; 33: 592-596. (Pubitemid 40592176)
40. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, Massague J. Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 2006; 125: 929-941. (Pubitemid 43795187)
41. Ransom DG, Bahary N, Niss K, Traver D, Burns C, Trede NS et al. The zebrafish moonshine gene encodes transcriptional intermediary factor 1gamma, an essential regulator of hematopoiesis. PLoS Biol 2004; 2: E237.
42. Bai X, Kim J, Yang Z, Jurynec MJ, Akie TE, Lee J et al. TIF1gamma controls erythroid cell fate by regulating transcription elongation. Cell 2010; 142: 133-143.
43. Monteiro R, Pouget C, Patient R. The gata1/pu.1 lineage fate paradigm varies between blood populations and is modulated by tif1gamma. EMBO J 2011; 30: 1093-1103.
44. Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 2005; 105: 2741-2748. (Pubitemid 40446264)
45. Perry JM, Harandi OF, Paulson RF. BMP4, SCF, and hypoxia cooperatively regulate the expansion of murine stress erythroid progenitors. Blood 2007; 109: 4494-4502. (Pubitemid 46743420)
46. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, Rugge M et al. Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 2005; 121: 87-99.
47. Morsut L, Yan KP, Enzo E, Aragona M, Soligo SM, Wendling O et al. Negative control of Smad activity by ectodermin/Tif1{gamma} patterns the mammalian embryo. Development 2010; 137: 2571-2578.
48. Kim J, Kaartinen V. Generation of mice with a conditional allele for Trim33. Genesis 2008; 46: 329-333. (Pubitemid 352008882)
49. Mishina Y, Suzuki A, Ueno N, Behringer RR. Bmpr encodes a type I bone morphogenetic protein receptor that is essential for gastrulation during mouse embryogenesis. Genes Dev 1995; 9: 3027-3037. (Pubitemid 26018138)
50. Winnier G, Blessing M, Labosky PA, Hogan BL. Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. Genes Dev 1995; 9: 2105-2116.
51. Zhang H, Bradley A. Mice deficient for BMP2 are nonviable and have defects in amnion/chorion and cardiac development. Development 1996; 122: 2977-2986. (Pubitemid 26371964)
52. Sadlon TJ, Lewis ID, D'Andrea RJ. BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor. Stem Cells 2004; 22: 457-474. (Pubitemid 39014563)
53. Maeno M, Mead PE, Kelley C, Xu RH, Kung HF, Suzuki A et al. The role of BMP-4 and GATA-2 in the induction and differentiation of hematopoietic mesoderm in Xenopus laevis. Blood 1996; 88: 1965-1972. (Pubitemid 26307898)
54. Huber TL, Zhou Y, Mead PE, Zon LI. Cooperative effects of growth factors involved in the induction of hematopoietic mesoderm. Blood 1998; 92: 4128-4137. (Pubitemid 28544329)
55. Schmid B, Furthauer M, Connors SA, Trout J, Thisse B, Thisse C et al. Equivalent genetic roles for bmp7/snailhouse and bmp2b/swirl in dorsoventral pattern formation. Development 2000; 127: 957-967. (Pubitemid 30162642)
56. Schmerer M, Evans T. Primitive erythropoiesis is regulated by Smad-dependent signaling in postgastrulation mesoderm. Blood 2003; 102: 3196-3205. (Pubitemid 37314756)
57. Gupta S, Zhu H, Zon LI, Evans T. BMP signaling restricts hematovascular development from lateral mesoderm during somitogenesis. Development 2006; 133: 2177-2187. (Pubitemid 43986128)
58. Chadwick K, Wang L, Li L, Menendez P, Murdoch B, Rouleau A et al. Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 2003; 102: 906-915. (Pubitemid 36917782)
59. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphogenetic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995; 15: 141-151. (Pubitemid 24379910)
60. Pearson S, Sroczynska P, Lacaud G, Kouskoff V. The stepwise specification of embryonic stem cells to hematopoietic fate is driven by sequential exposure to Bmp4, activin A, bFGF and VEGF. Development 2008; 135: 1525-1535. (Pubitemid 351753642)
61. Park C, Afrikanova I, Chung YS, Zhang WJ, Arentson E, Fong Gh G et al. A hierarchical order of factors in the generation of FLK1-and SCL-expressing hematopoietic and endothelial progenitors from embryonic stem cells. Development 2004; 131: 2749-2762. (Pubitemid 38877906)
62. Li F, Lu S, Vida L, Thomson JA, Honig GR. Bone morphogenetic protein 4 induces efficient hematopoietic differentiation of rhesus monkey embryonic stem cells in vitro. Blood 2001; 98: 335-342.
63. Lengerke C, Schmitt S, Bowman TV, Jang IH, Maouche-Chretien L, McKinney-Freeman S et al. BMP and Wnt specify hematopoietic fate by activation of the Cdx-Hox pathway. Cell Stem Cell 2008; 2: 72-82.
64. McReynolds LJ, Gupta S, Figueroa ME, Mullins MC, Evans T. Smad1 and Smad5 differentially regulate embryonic hematopoiesis. Blood 2007; 110: 3881-3890. (Pubitemid 350248443)
65. Hild M, Dick A, Rauch GJ, Meier A, Bouwmeester T, Haffter P et al. The smad5 mutation somitabun blocks Bmp2b signaling during early dorsoventral patterning of the zebrafish embryo. Development 1999; 126: 2149-2159. (Pubitemid 29271700)
66. McReynolds LJ, Tucker J, Mullins MC, Evans T. Regulation of hematopoiesis by the BMP signaling pathway in adult zebrafish. Exp Hematol 2008; 36: 1604-1615.
67. Singbrant S, Karlsson G, Ehinger M, Olsson K, Jaako P, Miharada K et al. Canonical BMP signaling is dispensable for hematopoietic stem cell function in both adult and fetal liver hematopoiesis, but essential to preserve colon architecture. Blood 2010; 115: 4689-4698.
68. Singbrant S, Moody JL, Blank U, Karlsson G, Umans L, Zwijsen A et al. Smad5 is dispensable for adult murine hematopoiesis. Blood 2006; 108: 3707-3712. (Pubitemid 44864548)
69. Zhang J, Niu C, Ye L, Huang H, He X, Tong WG et al. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 2003; 425: 836-841. (Pubitemid 37351467)
70. Bhatia M, Bonnet D, Wu D, Murdoch B, Wrana J, Gallacher L et al. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J Exp Med 1999; 189: 1139-1148.
71. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K et al. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2001; 2: 172-180. (Pubitemid 33707938)
72. Nolta JA, Thiemann FT, Arakawa-Hoyt J, Dao MA, Barsky LW, Moore KA et al. The AFT024 stromal cell line supports long-term ex vivo maintenance of engrafting multipotent human hematopoietic progenitors. Leukemia 2002; 16: 352-361. (Pubitemid 34223694)
73. Hutton JF, Rozenkov V, Khor FS, D0Andrea RJ, Lewis ID. Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system. Stem Cells Dev 2006; 15: 805-813. (Pubitemid 46147853)
74. Utsugisawa T, Moody JL, Aspling M, Nilsson E, Carlsson L, Karlsson S. A road map toward defining the role of Smad signaling in hematopoietic stem cells. Stem Cells 2006; 24: 1128-1136. (Pubitemid 44464746)
75. Blank U, Karlsson G, Moody JL, Utsugisawa T, Magnusson M, Singbrant S et al. Smad7 promotes self-renewal of hematopoietic stem cells. Blood 2006; 108: 4246-4254. (Pubitemid 44913300)
76. Chadwick K, Shojaei F, Gallacher L, Bhatia M. Smad7 alters cell fate decisions of human hematopoietic repopulating cells. Blood 2005; 105: 1905-1915. (Pubitemid 40731771)
77. Karlsson G, Blank U, Moody JL, Ehinger M, Singbrant S, Deng CX et al. Smad4 is critical for self-renewal of hematopoietic stem cells. J Exp Med 2007; 204: 467-474. (Pubitemid 46457070)
78. Labbe E, Letamendia A, Attisano L. Association of Smads with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways. Proc Natl Acad Sci USA 2000; 97: 8358-8363. (Pubitemid 30639677)
79. Nishita M, Hashimoto MK, Ogata S, Laurent MN, Ueno N, Shibuya H et al. Interaction between Wnt and TGF-beta signalling pathways during formation of Spemann's organizer. Nature 2000; 403: 781-785. (Pubitemid 30111840)
80. Itoh F, Itoh S, Goumans MJ, Valdimarsdottir G, Iso T, Dotto GP et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J 2004; 23: 541-551. (Pubitemid 38282386)
81. Dong M, Blobe GC. Role of transforming growth factor-beta in hematologic malignancies. Blood 2006; 107: 4589-4596. (Pubitemid 43882602)
82. Grady WM, Myeroff LL, Swinler SE, Rajput A, Thiagalingam S, Lutterbaugh JD et al. Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res 1999; 59: 320-324. (Pubitemid 29048861)
83. Villanueva A, Garcia C, Paules AB, Vicente M, Megias M, Reyes G et al. Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogene 1998; 17: 1969-1978. (Pubitemid 28488465)
84. Kim SJ, Letterio J. Transforming growth factor-beta signaling in normal and malignant hematopoiesis. Leukemia 2003; 17: 1731-1737.
85. Tang B, Bottinger EP, Jakowlew SB, Bagnall KM, Mariano J, Anver MR et al. Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. Nat Med 1998; 4: 802-807. (Pubitemid 28331021)
86. Zhu Y, Richardson JA, Parada LF, Graff JM. Smad3 mutant mice develop metastatic colorectal cancer. Cell 1998; 94: 703-714. (Pubitemid 28436003)
87. Imai Y, Kurokawa M, Izutsu K, Hangaishi A, Maki K, Ogawa S et al. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis. Oncogene 2001; 20: 88-96. (Pubitemid 32142341)
88. Yang L, Wang N, Tang Y, Cao X, Wan M. Acute myelogenous leukemia-derived SMAD4 mutations target the protein to ubiquitin-proteasome degradation. Hum Mutat 2006; 27: 897-905. (Pubitemid 44336939)
89. Molenaar JJ, Gerard B, Chambon-Pautas C, Cave H, Duval M, Vilmer E et al. Microsatellite instability and frameshift mutations in BAX and transforming growth factor-beta RII genes are very uncommon in acute lymphoblastic leukemia in vivo but not in cell lines. Blood 1998; 92: 230-233. (Pubitemid 28303197)
90. Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, Reimer C et al. Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res 2003; 27: 23-34. (Pubitemid 35449713)
91. Knaus PI, Lindemann D, DeCoteau JF, Perlman R, Yankelev H, Hille M et al. A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol Cell Biol 1996; 16: 3480-3489. (Pubitemid 26199867)
92. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A deletion in the gene for transforming growth factor beta type I receptor abolishes growth regulation by transforming growth factor beta in a cutaneous T-cell lymphoma. Blood 1999; 94: 2854-2861. (Pubitemid 29477314)
93. Wolfraim LA, Fernandez TM, Mamura M, Fuller WL, Kumar R, Cole DE et al. Loss of Smad3 in acute T-cell lymphoblastic leukemia. N Engl J Med 2004; 351: 552-559. (Pubitemid 39025172)
94. Komuro H, Valentine MB, Rubnitz JE, Saito M, Raimondi SC, Carroll AJ et al. p27KIP1 deletions in childhood acute lymphoblastic leukemia. Neoplasia 1999; 1: 253-261.
95. Takeuchi C, Takeuchi S, Ikezoe T, Bartram CR, Taguchi H, Koeffler HP. Germline mutation of the p27/Kip1 gene in childhood acute lymphoblastic leukemia. Leukemia 2002; 16: 956-958. (Pubitemid 34537574)
96. Jakubowiak A, Pouponnot C, Berguido F, Frank R, Mao S, Massague J et al. Inhibition of the transforming growth factor beta signaling pathway by the AML1/ETO leukemia-associated fusion protein. J Biol Chem 2000; 275: 40282-40287. (Pubitemid 32064660)
97. Kurokawa M, Mitani K, Imai Y, Ogawa S, Yazaki Y, Hirai H. The t(3;21) fusion product, AML1/Evi-1, interacts with Smad3 and blocks transforming growth factor-beta-mediated growth inhibition of myeloid cells. Blood 1998; 92: 4003-4012. (Pubitemid 28544312)
98. Lee DK, Kim BC, Brady JN, Jeang KT, Kim SJ. Human T-cell lymphotropic virus type 1 tax inhibits transforming growth factorbeta signaling by blocking the association of Smad proteins with Smad-binding element. J Biol Chem 2002; 277: 33766-33775.
99. Nakahata S, Yamazaki S, Nakauchi H, Morishita K. Downregulation of ZEB1 and overexpression of Smad7 contribute to resistance to TGF-beta1-mediated growth suppression in adult T-cell leukemia/lymphoma. Oncogene 2010; 29: 4157-4169.
100. Mitani K. Molecular mechanisms of leukemogenesis by AML1/EVI-1. Oncogene 2004; 23: 4263-4269. (Pubitemid 38758593)
101. Ford AM, Palmi C, Bueno C, Hong D, Cardus P, Knight D et al. The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells. J Clin Invest 2009; 119: 826-836.
102. Sood R, Talwar-Trikha A, Chakrabarti SR, Nucifora G. MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1. Leukemia 1999; 13: 348-357. (Pubitemid 29108073)
103. Wang N, Kim HG, Cotta CV, Wan M, Tang Y, Klug CA et al. TGFbeta/BMP inhibits the bone marrow transformation capability of Hoxa9 by repressing its DNA-binding ability. EMBO J 2006; 25: 1469-1480.
104. Quere R, Karlsson G, Hertwig F, Rissler M, Lindqvist B, Fioretos T et al. SMAD4 sequestrates HOXA9 to protect hematopoietic stem cells against leukemia transformation. Blood 2010; 116: 3153.
105. ShehataM, Schwarzmeier JD, Hilgarth M, Hubmann R, DuechlerM, Gisslinger H. TGF-beta1 induces bone marrow reticulin fibrosis in hairy cell leukemia. J Clin Invest 2004; 113: 676-685. (Pubitemid 38544160)
106. Le Bousse-Kerdiles MC, Chevillard S, Charpentier A, Romquin N, Clay D, Smadja-Joffe F et al. Differential expression of transforming growth factor-beta, basic fibroblast growth factor, and their receptors in CD34+ hematopoietic progenitor cells from patients with myelofibrosis and myeloid metaplasia. Blood 1996; 88: 4534-4546. (Pubitemid 26419136)
107. Chagraoui H, Komura E, Tulliez M, Giraudier S, Vainchenker W, Wendling F. Prominent role of TGF-beta 1 in thrombopoietininduced myelofibrosis in mice. Blood 2002; 100: 3495-3503. (Pubitemid 35303916)
108. Vannucchi AM, Bianchi L, Paoletti F, Pancrazzi A, Torre E, Nishikawa M et al. A pathobiologic pathway linking thrombopoietin, GATA-1, and TGF-beta1 in the development of myelofibrosis. Blood 2005; 105: 3493-3501. (Pubitemid 40628191)
109. Gluckman E. Recent trends in allogeneic bone marrow transplantation. Clin Transpl 1989; 123-128.
110. Attar EC, Scadden DT. Regulation of hematopoietic stem cell growth. Leukemia 2004; 18: 1760-1768. (Pubitemid 39530003)
111. Antonchuk J, Sauvageau G, Humphries RK. HOXB4-induced expansion of adult hematopoietic stem cells ex vivo. Cell 2002; 109: 39-45. (Pubitemid 34327515)
112. Baum C, Dullmann J, Li Z, Fehse B, Meyer J, Williams DA et al. Side effects of retroviral gene transfer into hematopoietic stem cells. Blood 2003; 101: 2099-2114. (Pubitemid 36302043)
113. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415-419. (Pubitemid 37296260)
114. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414. (Pubitemid 36626987)
115. Murdoch B, Chadwick K, Martin M, Shojaei F, Shah KV, Gallacher L et al. Wnt-5A augments repopulating capacity and primitive hematopoietic development of human blood stem cells in vivo. Proc Natl Acad Sci USA 2003; 100: 3422-3427. (Pubitemid 36356599)
116. Karanu FN, Murdoch B, Gallacher L, Wu DM, Koremoto M, Sakano S et al. The notch ligand jagged-1 represents a novel growth factor of human hematopoietic stem cells. J Exp Med 2000; 192: 1365-1372.
117. Zhang CC, Kaba M, Ge G, Xie K, Tong W, Hug C et al. Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med 2006; 12: 240-245. (Pubitemid 43214753)
118. Zhang CC, Kaba M, Iizuka S, Huynh H, Lodish HF. Angiopoietinlike and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. Blood 2008; 111: 3415-3423.
119. Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med 2010; 16: 232-236.
120. North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, Lord AM et al. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis. Nature 2007; 447: 1007-1011. (Pubitemid 46975751)
121. Boitano AE, Wang J, Romeo R, Bouchez LC, Parker AE, Sutton SE et al. Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells. Science 2010; 329: 1345-1348.
122. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003; 425: 577-584. (Pubitemid 37280136)
123. Yamaguchi K, Shirakabe K, Shibuya H, Irie K, Oishi I, Ueno N et al. Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction. Science 1995; 270: 2008-2011. (Pubitemid 26097194)
124. Blank U, Brown A, Adams DC, Karolak MJ, Oxburgh L. BMP7 promotes proliferation of nephron progenitor cells via a JNKdependent mechanism. Development 2009; 136: 3557-3566.
125. Tang M, Wei X, Guo Y, Breslin P, Zhang S, Wei W et al. TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice. J Exp Med 2008; 205: 1611-1619. (Pubitemid 351962025)
126. Kretzschmar M, Doody J, Massague J. Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1. Nature 1997; 389: 618-622. (Pubitemid 27446181)
127. Kretzschmar M, Doody J, Timokhina I, Massague J. A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev 1999; 13: 804-816. (Pubitemid 29169840)
128. Fuentealba LC, Eivers E, Ikeda A, Hurtado C, Kuroda H, Pera EM et al. Integrating patterning signals: Wnt/GSK3 regulates the duration of the BMP/Smad1 signal. Cell 2007; 131: 980-993. (Pubitemid 350138081)
129. Pera EM, Ikeda A, Eivers E, De Robertis EM. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev 2003; 17: 3023-3028. (Pubitemid 38040766)
130. de Haan G, Weersing E, Dontje B, van Os R, Bystrykh LV, Vellenga E et al. In vitro generation of long-term repopulating hematopoietic stem cells by fibroblast growth factor-1. Dev Cell 2003; 4: 241-251. (Pubitemid 36221800)